• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一名患有肝素诱导的血小板减少症的患者进行肾支架植入期间使用诺瓦斯坦进行抗凝治疗。

Novastan anticoagulation during renal stent implant in a patient with heparin-induced thrombocytopenia.

作者信息

Lewis B E, Grassman E D, Wrona L, Rangel Y

机构信息

Columbus Hospital, Chicago, IL 60614, USA.

出版信息

Blood Coagul Fibrinolysis. 1997 Jan;8(1):54-8. doi: 10.1097/00001721-199701000-00009.

DOI:10.1097/00001721-199701000-00009
PMID:9105638
Abstract

We describe a case of a 70-year-old male who underwent coronary artery bypass surgery which was complicated by multiple thrombotic events associated with HIT. The thrombotic events were treated with intravenous argatroban (Novastan). During the hospitalization the patient was found to require percutaneous bilateral renal artery revascularization for acute renal failure. The revascularization procedure was successfully accomplished with a high dose argatroban regimen. We present our report of a successful anticoagulation strategy during a peripheral intervention in a patient with HIT and the laboratory data which support this strategy.

摘要

我们描述了一例70岁男性患者,该患者接受了冠状动脉搭桥手术,术后并发了多起与肝素诱导的血小板减少症(HIT)相关的血栓形成事件。这些血栓形成事件采用静脉注射阿加曲班(诺瓦斯坦)进行治疗。住院期间,发现该患者因急性肾衰竭需要进行经皮双侧肾动脉血运重建术。通过高剂量阿加曲班方案成功完成了血运重建手术。我们报告了在一名HIT患者进行外周介入治疗期间成功的抗凝策略以及支持该策略的实验室数据。

相似文献

1
Novastan anticoagulation during renal stent implant in a patient with heparin-induced thrombocytopenia.在一名患有肝素诱导的血小板减少症的患者进行肾支架植入期间使用诺瓦斯坦进行抗凝治疗。
Blood Coagul Fibrinolysis. 1997 Jan;8(1):54-8. doi: 10.1097/00001721-199701000-00009.
2
[Heparin-induced thrombocytopenia after on-pump coronary artery bypass grafting].体外循环冠状动脉搭桥术后肝素诱导的血小板减少症
Kyobu Geka. 2010 Jun;63(6):442-5.
3
[A case of heparin-induced thrombocytopenia associated with unexpected excessive argatroban anticoagulation after abdominal aortic aneurysm resection].[1例腹主动脉瘤切除术后肝素诱导的血小板减少症合并意外的阿加曲班抗凝过度]
Masui. 2006 Feb;55(2):188-92.
4
Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use.肝素诱导的血小板减少症与体外循环:围手术期使用阿加曲班
Ann Thorac Surg. 2003 Feb;75(2):577-9. doi: 10.1016/s0003-4975(02)04309-6.
5
The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report.首例使用阿加曲班抗凝成功植入颈动脉支架治疗肝素诱导的血小板减少症和血栓形成综合征患者:病例报告
Angiology. 1998 Jan;49(1):61-7. doi: 10.1177/000331979804900108.
6
Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.怀疑肝素诱导的血小板减少症合并 Child-Pugh 分级 C 级肝病时,降低阿加曲班剂量。
Ann Pharmacother. 2012 Nov;46(11):e30. doi: 10.1345/aph.1R226. Epub 2012 Oct 16.
7
Systemic infusion and local irrigation with argatroban effective in preventing clot formation during carotid endarterectomy in a patient with heparin-induced thrombocytopenia.阿加曲班全身输注联合局部灌洗在肝素诱导的血小板减少症患者颈动脉内膜剥脱术中预防血栓形成的有效性。
World Neurosurg. 2013 Jul-Aug;80(1-2):222.e15-8. doi: 10.1016/j.wneu.2013.01.037. Epub 2013 Jan 12.
8
Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
Semin Thromb Hemost. 1997;23(2):197-202. doi: 10.1055/s-2007-996091.
9
Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.阿加曲班用于需要肾脏替代治疗的肝素诱导的血小板减少症患者的抗凝治疗。
Ann Pharmacother. 2005 Oct;39(10):1601-5. doi: 10.1345/aph.1G033. Epub 2005 Aug 30.
10
Concomitant use of argatroban and warfarin during hemodialysis in heparin-induced thrombocytopenia.肝素诱导的血小板减少症患者血液透析期间阿加曲班与华法林的联合使用。
Hematology. 2015 Jan;20(1):48-9. doi: 10.1179/1607845414Y.0000000157. Epub 2014 Feb 28.

引用本文的文献

1
Benefit-risk assessment of treatments for heparin-induced thrombocytopenia.肝素诱导的血小板减少症治疗的获益-风险评估
Drug Saf. 2003;26(9):625-41. doi: 10.2165/00002018-200326090-00003.
2
Argatroban.阿加曲班
Drugs. 2001;61(4):515-22; discussion 523-4. doi: 10.2165/00003495-200161040-00005.